Metabolic Medications and Youth Hospitalizations for Asthma: A Pre-Post Quasi-Experimental Study.

ABSTRACT:

Background

Obesity and metabolic dysregulation can lead to adverse outcomes in people with asthma. We hypothesized that pharmacological treatment of metabolic conditions in youth with asthma is associated with lowered risk of severe asthma exacerbations.

Research question

Is metabolic pharmacotherapy associated with a lower risk of severe asthma exacerbations among children and young adults with metabolic dysregulation?

Study design and methods

This retrospective, quasi-experimental, longitudinal study examined severe asthma exacerbations (those requiring hospitalization or an emergency department [ED] visit) among youth aged 5-25 years with asthma and a history of a metabolic condition (obesity, diabetes, or hypertension). Definitions and diagnoses were based on docu

SUBMITTER: Aguree S 

PROVIDER: S-EPMC12422118 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature